Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP165145.RACMZTd9Tg_YxQIKA4cHJ2T8RpW3VSSkjnGl6hxYCIVpc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP165145.RACMZTd9Tg_YxQIKA4cHJ2T8RpW3VSSkjnGl6hxYCIVpc130_assertion type Assertion NP165145.RACMZTd9Tg_YxQIKA4cHJ2T8RpW3VSSkjnGl6hxYCIVpc130_head.
- NP165145.RACMZTd9Tg_YxQIKA4cHJ2T8RpW3VSSkjnGl6hxYCIVpc130_assertion description "[The ENPP1 121Gln and IRS-1 972Arg polymorphisms affecting insulin receptor activity predispose to liver damage and decrease hepatic insulin signalling in patients with NAFLD. Defective insulin signalling may play a causal role in the progression of liver ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165145.RACMZTd9Tg_YxQIKA4cHJ2T8RpW3VSSkjnGl6hxYCIVpc130_provenance.
- NP165145.RACMZTd9Tg_YxQIKA4cHJ2T8RpW3VSSkjnGl6hxYCIVpc130_assertion evidence source_evidence_literature NP165145.RACMZTd9Tg_YxQIKA4cHJ2T8RpW3VSSkjnGl6hxYCIVpc130_provenance.
- NP165145.RACMZTd9Tg_YxQIKA4cHJ2T8RpW3VSSkjnGl6hxYCIVpc130_assertion SIO_000772 20176643 NP165145.RACMZTd9Tg_YxQIKA4cHJ2T8RpW3VSSkjnGl6hxYCIVpc130_provenance.
- NP165145.RACMZTd9Tg_YxQIKA4cHJ2T8RpW3VSSkjnGl6hxYCIVpc130_assertion wasDerivedFrom gad-20150221 NP165145.RACMZTd9Tg_YxQIKA4cHJ2T8RpW3VSSkjnGl6hxYCIVpc130_provenance.
- NP165145.RACMZTd9Tg_YxQIKA4cHJ2T8RpW3VSSkjnGl6hxYCIVpc130_assertion wasGeneratedBy ECO_0000203 NP165145.RACMZTd9Tg_YxQIKA4cHJ2T8RpW3VSSkjnGl6hxYCIVpc130_provenance.